Louisiana 2016 Regular Session

Louisiana House Bill HB283

Introduced

3/2/16

Refer

3/2/16

Refer

3/2/16

Refer

3/14/16

Refer

3/14/16

Report Pass

5/4/16

Report Pass

5/4/16

Engrossed

5/12/16

Engrossed

5/12/16

Refer

5/16/16

Refer

5/16/16

Report Pass

5/24/16

Refer

5/25/16

Refer

5/25/16

Report Pass

6/2/16

Report Pass

6/2/16

Enrolled

6/6/16

Enrolled

6/6/16

Chaptered

6/16/16

Chaptered

6/16/16

Passed

6/16/16

Passed

6/16/16

Caption

Requires screening of newborns for Krabbe disease (EN +$798,907 GF EX See Note)

Latest LA HB283 Activity

View All Events: LA 2016 Regular Session HB283

Companion Bills

No companion bills found.

Previously Filed As

LA HB316

Adds mucopolysaccharidosis type I and glycogen storage disorder type II to the state's newborn screening panel (EN +$187,717 GF EX See Note)

LA HB122

Provides relative to the mandatory screening of all newborns for early detection of the cytomegalovirus (CMV) (OR NO IMPACT See Note)

LA HB200

Provides relative to newborn screening for certain genetic conditions (EN SEE FISC NOTE GF EX See Note)

LA HB157

Requires all newborns to be screened for adrenoleukodystrophy

LA HB291

Adds mucopolysaccharidosis type I and glycogen storage disorder type II to the state's newborn screening panel

LA SB105

AN ACT relating to newborn and infant screenings.

LA HB374

AN ACT relating to newborn and infant screenings.

LA HB2798

Relating to requiring the Health Department to mandate mucopolysaccharidosis type 1 (MPS1) test for newborn babies, to be known as Embie’s Law

LA HB76

Congenital Heart Disease Tests For Infants

LA SB00285

An Act Concerning Newborn Screening For Krabbe Disease.

Similar Bills

No similar bills found.